Source: Pandaily
Neuracle NEO-ONE SCI receives first prescription at Shanghai Huashan Hospital, completing the world first full commercial cycle of an invasive BCI device from approval to surgery to insurance coverage.
Read the full article at the source →
İlk yorumu siz yazın!
Yorum
Ad
E-posta
Save my name, email, and website in this browser for the next time I comment.
Gönder
Comments
İlk yorumu siz yazın!